Viewing Study NCT00235820


Ignite Creation Date: 2025-12-25 @ 4:17 AM
Ignite Modification Date: 2025-12-26 @ 3:17 AM
Study NCT ID: NCT00235820
Status: COMPLETED
Last Update Posted: 2008-07-17
First Post: 2005-10-07
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Safety and Efficacy of Adalimumab to Methotrexate and Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis
Sponsor: Abbott
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2005-07
Start Date Type: None
Primary Completion Date: 2006-05
Primary Completion Date Type: ACTUAL
Completion Date: None
Completion Date Type: None
First Submit Date: 2005-10-07
First Submit QC Date: None
Study First Post Date: 2005-10-12
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2008-07-15
Last Update Post Date: 2008-07-17
Last Update Post Date Type: ESTIMATED